|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Neo Comprehensive- Myeloid Disorders
Test CodeLAB6573
Alias/See Also
Comprehensive Myeloid Disorders, Myeloid CGP, Comprehensive Myeloid
CPT Codes
81455
Preferred Specimen
- Bone Marrow Aspirate: 2-3 mL in EDTA tube
- Peripheral Blood: 3-5 mL in EDTA tube
- FFPE tissue: Paraffin block. Alternatively, send 1 H&E slide plus 10-14 unstained slides cut at 5 or more microns. Please use positively-charged slides and 10% NBF fixative is the recommended fixative. Do not use zinc or mercury fixatives (B5). Highly acidic or prolonged decalcification processes will not yield sufficient nucleic acid to accurately perform molecular studies.
Instructions
Test is not suitable for Freeze & Hold option
Transport Container
Use refrigerated cold pack for transport. Make sure cold pack is not in direct contact with specimen. Ship same day as drawn whenever possible; specimens <7 days old preferred.
Methodology
Molecular
Report Available
14 days
Clinical Significance
The Neo Comprehensive - Myeloid Disorders assay detects relevant aberrations for the purpose of diagnostic evaluation, prognosis, risk stratification, and therapy guidance. It covers a wide spectrum of myeloid neoplasms, including acute myeloid leukemia (AML); chronic myeloid leukemia (CML); chronic myelomonocytic leukemia (CMML); myelodysplastic neoplasms (MDS); myeloproliferative neoplasms (MPN), e.g., polycythemia vera (PV), primary myelofibrosis (PMF), and essential thrombocythemia (ET); myeloid neoplasms with eosinophilia and defining gene rearrangement; histiocytic neoplasms, such as Langerhans cell histiocytosis (LCH) or Erdheim-Chester Disease (ECD); mastocytosis; myeloid precursor lesions.
Performing Laboratory
Neogenomics Laboratories
